PERP expression stabilizes active p53 via modulation of p53-MDM2 interaction in uveal melanoma cells

Cell Death and Disease

Volumn 2, Issue 3, 2011, Pages

  Davies, L ^a   D Spiller, D ^a   White, M R H ^a   Grierson, I ^a   Paraoan, L ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Apoptosis; Fluorescent protein; P53; PERP; Uveal melanoma

Indexed keywords

P53 APOPTOSIS EFFECTOR RELATED TO PMP 22; PERIPHERAL MYELIN PROTEIN 22; PROTEIN MDM2; PROTEIN P53; UNCLASSIFIED DRUG; MDM2 PROTEIN, HUMAN; MEMBRANE PROTEIN; PERP PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MELANOMA CELL; MODULATION; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; UVEA MELANOMA; APOPTOSIS; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; MELANOMA; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN STABILITY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; UVEA TUMOR;

APOPTOSIS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION; GENES, TUMOR SUPPRESSOR; HUMANS; MELANOMA; MEMBRANE PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN STABILITY; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53; UVEAL NEOPLASMS;

EID: 79959939374     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2011.19     Document Type: Article

References (40)

1. Levine AJ, Hu W, Feng Z. The P53 pathway: what questions remain to be explored? Cell Death Differ 2006; 13: 1027-1036.
2. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323-331. (Pubitemid 27131374)
3. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408: 307-310.
4. Attardi LD, Reczek EE, Cosmas C, Demicco EG, McCurrach ME, Lowe SW et al. PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family. Genes Dev 2000; 14: 704-718. (Pubitemid 30176824)
5. Davies L, Gray D, Spiller D, White MR, Damato B, Grierson I et al. P53 apoptosis mediator PERP: localization, function and caspase activation in uveal melanoma. J Cell Mol Med 2009; 13: 1995-2007.
6. Ihrie RA, Reczek E, Horner JS, Khachatrian L, Sage J, Jacks T et al. Perp is a mediator of p53-dependent apoptosis in diverse cell types. Curr Biol 2003; 13: 1985-1990. (Pubitemid 37425209)
7. Nowak M, Koster C, Hammerschmidt M. Perp is required for tissue-specific cell survival during zebrafish development. Cell Death Differ 2005; 12: 52-64. (Pubitemid 40090028)
8. Singaravelu K, Devalaraja-Narashimha K, Lastovica B, Padanilam BJ. PERP, a p53 proapoptotic target, mediates apoptotic cell death in renal ischemia. Am J Physiol Renal Physiol 2009; 296: F847-F858.
9. Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene 2005; 24: 2899-2908. (Pubitemid 40638098)
10. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387: 296-299. (Pubitemid 27220766)
11. Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 1997; 387: 299-303. (Pubitemid 27220767)
12. Appella E, Anderson CW. Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 2001; 268: 2764-2772. (Pubitemid 32862957)
13. Shieh SY, Ikeda M, Taya Y, Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997; 91: 325-334. (Pubitemid 27467963)
14. Mayo LD, Seo YR, Jackson MW, Smith ML, Rivera Guzman J, Korgaonkar CK et al. Phosphorylation of human p53 at serine 46 determines promoter selectionand whether apoptosis is attenuated or amplified. J Biol Chem 2005; 280: 25953-25959. (Pubitemid 41022185)
15. O'Brate A, Giannakakou P. The importance of p53 location: nuclear or cytoplasmic zip code? Drug Resist Updat 2003; 6: 313-322. (Pubitemid 38173582)
16. Tao W, Levine AJ. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2- mediated degradation of p53. Proc Natl Acad Sci USA 1999; 96: 3077-3080. (Pubitemid 29148846)
17. Paraoan L, Gray D, Hiscott P, Ebrahimi B, Damato B, Grierson I. Expression of p53- induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type. Exp Eye Res 2006; 83: 911-919. (Pubitemid 44292688)
18. Hildebrandt T, Preiherr J, Tarbe N, Klostermann S, Van Muijen GN, Weidle UH. Identification of THW, a putative new tumor suppressor gene. Anticancer Res 2000; 20: 2801-2809.
19. Verbik DJ, Murray TG, Tran JM, Ksander BR. Melanomas that develop within the eye inhibit lymphocyte proliferation. Int J Cancer 1997; 73: 470-478. (Pubitemid 28005307)
20. Lahav G, Rosenfeld N, Sigal A, Geva-Zatorsky N, Levine AJ, Elowitz MB et al. Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat Genet 2004; 36: 147-150. (Pubitemid 38174372)
21. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999; 285: 1733-1737. (Pubitemid 29428873)
22. Tibbetts RS, Brumbaugh KM, Williams JM, Sarkaria JN, Cliby WA, Shieh SY et al. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev 1999; 13: 152-157. (Pubitemid 29061945)
23. Chehab NH, Malikzay A, Stavridi ES, Halazonetis TD. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc Natl Acad Sci USA 1999; 96: 13777-13782.
24. Shieh SY, Taya Y, Prives C. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J 1999; 18: 1815-1823. (Pubitemid 29158525)
25. Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T et al. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 2000; 102: 849-862.
26. Perfettini JL, Castedo M, Nardacci R, Ciccosanti F, Boya P, Roumier T et al. Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope. J Exp Med 2005; 201: 279-289. (Pubitemid 40189437)
27. Bulavin DV, Saito S, Hollander MC, Sakaguchi K, Anderson CW, Appella E et al. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 1999; 18: 6845-6854.
28. D'Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S et al. Homeodomaininteracting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 2002; 4: 11-19.
29. Hofmann TG, Moller A, Sirma H, Zentgraf H, Taya Y, Droge W et al. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 2002; 4: 1-10. (Pubitemid 34071974)
30. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9: 402-412. (Pubitemid 351574202)
31. Bosari S, Viale G, Roncalli M, Graziani D, Borsani G, Lee AK et al. p53 gene mutations, p53 protein accumulation and compartmentalization in colorectal adenocarcinoma. Am J Pathol 1995; 147: 790-798.
32. Moll UM, LaQuaglia M, Benard J, Riou G. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci USA 1995; 92: 4407-4411.
33. Vousden KH. Outcomes of p53 activation - spoilt for choice. J Cell Sci 2006; 119: 5015-5020. (Pubitemid 46085181)
34. Xirodimas DP, Stephen CW, Lane DP. Cocompartmentalization of p53 and Mdm2 is a major determinant for Mdm2-mediated degradation of p53. Exp Cell Res 2001; 270: 66-77. (Pubitemid 32978090)
35. Rinaldo C, Prodosmo A, Mancini F, Iacovelli S, Sacchi A, Moretti F et al. MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Mol Cell 2007; 25: 739-750. (Pubitemid 46341925)
36. Sun Y, Tran BN, Worley LA, Delston RB, Harbour JW. Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma. Invest Ophthalmol Vis Sci 2005; 46: 1561-1564. (Pubitemid 44843586)
37. Yee KS, Vousden KH. Complicating the complexity of p53. Carcinogenesis 2005; 26:1317-1322. (Pubitemid 41430092)
38. Brantley Jr MA, Harbour JW. Deregulation of the Rb and p53 pathways in uveal melanoma. Am J Pathol 2000; 157: 1795-1801.
39. Kishore K, Ghazvini S, Char DH, Kroll S, Selle J. p53 gene and cell cycling in uveal melanoma. Am J Ophthalmol 1996; 121: 561-567. (Pubitemid 26135865)
40. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with ImageJ. Biophotonics Int 2004; 11: 36-42.